FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003183334> ?p ?o ?g. }

• W2003183334 endingPage "R1369" @default.
• W2003183334 startingPage "R1365" @default.
• W2003183334 abstract "APPETITE, OBESITY, AND DIGESTIONFructose-induced leptin resistance: discovery of an unsuspected form of the phenomenon and its significance. Focus on “Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding,” by Shapiro et al.Joseph R. VasselliJoseph R. VasselliPublished Online:01 Nov 2008https://doi.org/10.1152/ajpregu.90674.2008This is the final version - click for previous versionMoreSectionsPDF (76 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations Brief Historical Perspectivethe concept of leptin resistance appeared in the literature almost as soon as the hormone itself was discovered. For purposes of our discussion, leptin resistance will be defined as, “reduced or absent responsiveness to the feeding and body weight inhibitory effects of the hormone in obese individuals in comparison with normal (lean) controls.” Two early reports, demonstrating significant correlations in humans between circulating leptin levels and increasing adiposity, came to the conclusion that resistance to the purported regulatory role of leptin on appetite and body weight must be induced as levels of the hormone increase (18, 43). In short order, the concept of leptin resistance was given experimental support by the finding of decreased ratios of cerebrospinal fluid vs. plasma levels of leptin in obese humans (14, 61). Parallel findings were made at almost the same time in obese rodents (24, 73). Whatever its mechanism, the notion of leptin resistance provided a ready explanation for excess body fat in individuals in the face of extremely high circulating leptin levels. Despite rather compelling initial observations, the notion of leptin resistance remained controversial at early stages of its advancement (4), or was reinterpreted in terms of individual variability in genetically determined leptin response thresholds (56). In fairness, these reviews appeared prior to experimental evidence demonstrating the existence of leptin resistance in obese humans (28, 31, 44). Moreover, findings of significant associations between leptin receptor gene polymorphisms and body mass index, fat mass, and eating behavior in humans were subsequently published (15, 21, 69). Nevertheless, it was not until experimental demonstrations of the phenomenon in outbred animals and subsequent analyses of the biological mechanisms involved that the notion gained widespread acceptance.Experimental leptin resistance was first demonstrated in wild-type mice made obese on a high-fat (HF) diet (13). This was followed by numerous reports of leptin resistance in diet-induced obese rodent models in response to central and/or peripheral administration of leptin (25, 70, 72). More careful behavioral analysis of the sequence of events in the induction of diet-induced leptin resistance revealed what appeared to be a two-step process over successive weeks of HF feeding, with the expression of first peripheral, and then central, leptin resistance (23, 39). Parallel work on potential biological mechanisms underlying leptin resistance revealed the saturation at elevated circulating leptin levels of an active blood-brain barrier (BBB) leptin transport mechanism (7, 12), reduced hypothalamic leptin receptor expression (42, 66), and the inhibition of hypothalamic leptin receptor signal transducer and activator of transcription-3 (STAT-3) second messenger signaling (23) in HF-fed animals. Evidence indicates that these biological events may well parallel the behavioral sequence described above in the induction of leptin resistance (23, 38). Newer observations have confirmed earlier findings of leptin receptor downregulation and reduced leptin binding at hypothalamic sites (32, 40), and additional work has expanded our understanding of the second messenger alterations underlying central leptin resistance. Thus, two intracellular inhibitory factors have been identified (9, 74), suppressor of cytokine signaling-3 and protein tyrosine phosphatase-1B, which reduce leptin receptor signaling by preventing activation of or dephosphorylating the janus-kinase component of the receptor, respectively. These discoveries have permitted a more sophisticated analysis of second messenger mechanisms potentially contributing to central leptin resistance when circulating leptin levels become elevated (29, 52). Leptin resistance is today recognized as a significant contributor to obesity with interest focused on its potential role in the onset vs. maintenance of the obese state (3, 45, 59).The New Finding and Its SignificanceNow comes a report from Shapiro et al. (60) of a hitherto unsuspected form of leptin resistance based on dietary administration of a high concentration of fructose. Basically, outbred Sprague-Dawley rats fed a 60% fructose diet (by weight) for 6 mo failed to reduce 24-h food intake in response to intraperitoneal leptin administration in contrast to a control group consuming an equicaloric 60% starch diet for the same period of time. Lack of response in the fructose-consuming group was associated with an ∼26% reduction in hypothalamic STAT-3 phosphorylation. Subsequent exposure of previously fructose-fed rats to a HF diet resulted in 65% greater body weight gain over a 2-wk period, in comparison with body weight gain in HF-fed control rats. Moreover, serum triglyceride (TG) levels in the fructose-fed rats were positively correlated with the reduced anorectic response after leptin injection and with degree of body weight gain when the rats were placed on the HF diet. These results are remarkable for several reasons. First, two of the hallmarks in the induction of diet-induced leptin resistance are elevated body weight (primarily fat) levels and increased circulating leptin concentrations. In the current study, after 6 mo of fructose feeding, circulating leptin levels, body weight, and body fat of the fructose-fed group were identical to those of the control group. This alone renders the phenomenon a unique form of diet-induced leptin resistance. Second, leptin resistance induced by fructose feeding led to a pronounced susceptibility to increased weight gain on an already potent obesity-inducing 60% HF diet. Third, as the authors note, fructose-induced leptin resistance has the characteristics of a “silent” form of the phenomenon, remaining undetectable (with one exception) by standard measures of food intake, body weight gain, and serum hormone and metabolite levels, until a HF diet is made available to previously fructose-fed rats.The one exception, elevated circulating TG in the fructose-fed rats even prior to exposure to the HF diet, appears, however, to provide us with both a potential marker for this syndrome and to cast light on the probable mechanism underlying this phenomenon. As the authors note, Banks et al. (6) have previously shown that elevated serum TGs reduce BBB leptin transport in rats. Indeed in this experiment, the investigators (6) demonstrated acute in vivo leptin resistance in rats for leptin transport across the BBB in response to intravenously infused TG. This observation is thus consistent with leptin resistance accompanying elevated TG in the fructose-fed rats of the current study. Alternatively, as the authors also note, fructose may directly reduce STAT-3 signaling in brain, as suggested by earlier results obtained in peripheral (hepatic) tissue (55). However, it is unclear whether fructose has access to hypothalamic tissue, since this form of hexose cannot cross the BBB (47, 50). Whether one or both of these mechanisms is involved can, of course, be readily tested by examining the effects on feeding and weight gain of peripheral vs. central leptin injections in fructose-fed rats. In addition, cerebrospinal fluid levels of leptin in fructose-fed rats can be sampled and compared to levels in controls (see Ref. 73). If such tests reveal that the leptin resistance induced by fructose is based exclusively on TG-mediated impairment of leptin transport across the BBB, with no additional induced hypothalamic defect, then this adds to the uniqueness of the phenomenon as a form of diet-induced leptin resistance.A survey of the existing literature reveals further clues that impaired leptin transport at the BBB may indeed be an explanation for the current results. Two studies (37, 71) examined the rapidity of onset of leptin resistance in HF-fed rats and noted that HF diet-induced leptin resistance for feeding inhibition occurred after only brief intervals of HF diet access (3–5 days). In the case of the former study (37), leptin resistance occurred prior to any significant body weight change. In both cases, the authors came to the conclusion that dietary fat may induce leptin resistance within a short period of time. Unfortunately, TG levels were not measured in either study. To be sure, onset of leptin resistance on HF diets is not always this rapid (23, 68) and is probably dependent, not only on the percent and composition of the fat and carbohydrate components of the diet, but also on strain and environmental conditions (10, 30). Nevertheless there is reasonable evidence to support the hypothesis of TG-mediated fructose-induced leptin resistance. This notion undoubtedly would come as no surprise to Banks (5), who suggested that BBB-based leptin resistance may, in fact, be the major form of the phenomenon in humans. What is perhaps surprising about this phenomenon to investigators familiar with leptin resistance protocols is its simplicity, uniqueness, and prolonged effects on HF diet-induced weight gain.Is the Phenomenon Specific To Fructose?As the above discussion implies, major questions exist concerning the specificity of this effect for the sugar fructose. To address these, several crucial control conditions should accompany the next demonstration of fructose-induced leptin resistance, including parallel groups of rats consuming equal and greater amounts of glucose and sucrose (which itself contains a glucose and a fructose moiety), such that both total control sugar and total fructose intake are calorically equated. In addition, one would also want to test the effects of feeding high concentrations of TG-promoting dietary lipids, such as long-chain fats; although, in this case, increases of TG level associated with leptin resistance would have to be demonstrated prior to any elevation of leptin levels and body fat. If such dietary sugar and fat feeding tests prove positive, then fructose-induced leptin resistance would have to be considered one example of TG-induced leptin resistance, nonetheless informative and replete with clinical implications. The issue of fructose-induced body weight gain also comes to bear here. In spite of the induction of leptin resistance, feeding of a high concentration of fructose in the diet resulted in no differential body weight gain in fructose-fed rats in the current study (60). However, other workers have observed fructose-induced body weight gain in rodents when fructose was offered in solution or as a component of the diet (34, 46). These latter results are more consistent with the establishment of leptin resistance and raise the issue of under what conditions fructose-induced leptin resistance remains “silent.” Is it as simple as a concentration of dietary fat in the fructose-containing diet that fails to cross the threshold for the expression of leptin resistance? Or is dietary fat providing some other essential leptin-inhibitory signal? Finally other sugars, such as sucrose, are known to elevate circulating TG and induce body weight gain and obesity in rodents (1, 35). Thus, in studies seeking to demonstrate carbohydrate-induced leptin resistance, whether specific to fructose or not, care must be taken to distinguish between leptin-resistant effects based on TG elevations per se vs. those in which elevated adiposity and/or leptin levels may potentially be involved.One irony about the present finding is that it involves the feeding of fructose, a form of sugar present in both fruits and processed foods associated with potentially pathogenic peripheral metabolic effects (11, 33). The irony, of course, is that in this case (60), we have a hitherto unsuspected but demonstrably detrimental effect of fructose based directly on its effects on brain. However, given the multiple peripheral metabolic and hormonal effects of fructose (27), one might reasonably ask whether peripheral mechanisms stimulated by fructose may independently attenuate the effects of injected leptin. Thus a recent human study demonstrated that fructose consumed with meals, in contrast to glucose, not only elevated circulating TG, but failed to reduce postprandial ghrelin levels and also lowered circulating levels of insulin and leptin, all effects that would be expected to reduce satiety (65). These results have been questioned, however, in several additional studies in which not only hormone and metabolite levels, but also satiety responses following administration of fructose and other sugar solutions were measured, with no satiety differences detected between test conditions (2, 62, 63). To further complicate the issue, in earlier studies, significantly greater reductions of caloric intake were observed following fructose vs. glucose preloads in lean and overweight humans, leading the investigators to conclude that fructose may acutely enhance satiety (53, 54). Clearly, the human appetitive response to sugar preloads is complexly determined. Note that no differences of insulin or leptin levels between fructose- and control-fed groups were seen in the Shapiro et al. (60) study, in which leptin resistance was demonstrated. Finally, fructose is well known to induce insulin resistance (8, 19), and hypothalamic insulin resistance for feeding inhibition has been well documented (17, 22). Thus the question arises as to whether insulin resistance may be contributing to the leptin resistance observed with fructose feeding. This possibility seems unlikely, however, in light of the recent finding that in contrast to their effects on leptin, elevated circulating TGs enhance BBB insulin transport (67).Implications of the FindingLeptin resistance is relatively easy to establish in rodents, and the study of its experimental determinants and underlying mechanisms has advanced rapidly. In contrast, studies demonstrating human leptin resistance and its effects are few indeed. Such studies have almost exclusively been correlational, examining the relationship between leptin levels and adiposity (16, 36, 69) or have been focused on specific metabolic or behavioral effects of leptin in lean vs. obese individuals (41, 57, 64). In short, our knowledge of the extent of and mechanisms underlying human leptin resistance is fragmentary at best. It should be noted that studies of leptin resistance in obese humans would require experimental administration of high doses of the hormone, and would necessitate both FDA and sponsor approval. Needless to say, such studies would be both risky and costly. The opportunity now presents itself to induce leptin resistance in humans with a relatively simple procedure limited to safe and reversible nutritional manipulations. In principle, lean subjects could be used in such studies, although individuals at risk for obesity would be of more interest. Leptin doses required for testing would be considerably smaller. The way has already been paved with numerous studies of the effects of fructose and other sugars on hormonal and appetitive responses in human subjects. Most of these studies have utilized short-term fructose and other sugar administration. However, the Shapiro et al. study (60) suggests that longer dietary intervention may be required. This may be based on the more sustained TG elevations characteristic of high carbohydrate feeding, which tends to increase very low-density lipoprotein TG concentrations (51). Nevertheless, studies examining the required time of onset, specific nutritional determinants, and behavioral effects of carbohydrate- or fat-induced leptin resistance in humans appear feasible. Note that the concept of insulin resistance was well known before safe and effective techniques for its measurement were developed (20, 26, 48, 49). The value of finding a specific protocol that reliably induces leptin resistance in at least some individuals would be considerable. First, it would permit an examination of the extent and characteristics of human leptin resistance. For example, are both the appetite- and energy-expenditure-altering effects of leptin compromised in the leptin resistance state, and, if so, do these deficits occur simultaneously (see Ref. 58)? Second, if elevated circulating TG can be shown to be a reliable marker of leptin resistance in humans, the role of leptin resistance in the onset and maintenance of obesity can potentially be investigated, and rational interventions based on this knowledge can perhaps be designed. Finally, if dietary fructose can itself be identified as one cause of leptin resistance, this result would undoubtedly add to the long list of warnings issued concerning the use of fructose in the human diet. We eagerly await further developments arising from this exciting finding.REFERENCES1 Ackroff K, Sclafani A. Sucrose-induced hyperphagia and obesity in rats fed a macronutrient self-selection diet. Physiol Behav 44: 181–187, 1988.Crossref | PubMed | ISI | Google Scholar2 Akhavan T, Anderson GH. Effects of glucose-to-fructose ratios in solutions on subjective satiety, food intake, and satiety hormones in young men. Am J Clin Nutr 86: 1354–1363, 2007.Crossref | PubMed | ISI | Google Scholar3 Arch JR. Central regulation of energy balance: inputs, outputs and leptin resistance. Proc Nutr Soc 64: 39–46, 2005.Crossref | PubMed | ISI | Google Scholar4 Arch JRS, Stock MJ, Trayhurn P. Leptin resistance in obese humans: does it exist and what does it mean? Int J Obes 22: 1159–1163, 1998.Crossref | ISI | Google Scholar5 Banks WA. The many lives of leptin. Peptides 25: 331–338, 2004.Crossref | PubMed | ISI | Google Scholar6 Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, Morley JE. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 53: 1253–1260, 2004.Crossref | PubMed | ISI | Google Scholar7 Banks WA, DiPalma CR, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20: 1341–1345, 1999.Crossref | PubMed | ISI | Google Scholar8 Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia (NOT AN ABSTRACT). Nutr Metab (Lond) 2: 5–29, 2005.Crossref | PubMed | Google Scholar9 Bjørbæk C, Elmquist JK, Frantz JD, Shoelson SE, Flier JS. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1: 619–625, 1998.Crossref | PubMed | ISI | Google Scholar10 Bowen H, Mitchell TD, Harris RB. Method of leptin dosing, strain, and group housing influence leptin sensitivity in high-fat-fed weanling mice. Am J Physiol Regul Integr Comp Physiol 284: R87–R100, 2003.Link | ISI | Google Scholar11 Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79: 537–543, 2004.Crossref | PubMed | ISI | Google Scholar12 Burguera B, Couce ME, Curran GL, Jensen MD, Lloyd R, Cleary MP, Poduslo JF. Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49: 1219–1223, 2000.Crossref | PubMed | ISI | Google Scholar13 Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546–549, 1995.Crossref | PubMed | ISI | Google Scholar14 Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348: 159–161, 1996.Crossref | PubMed | ISI | Google Scholar15 Chagnon YC, Wilmore JH, Borecki IB, Gagnon J, Pérusse L, Gagnon M, Collier GR, Leon AS, Skinner JS, Rao DC, Bouchard C. Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study. J Clin Endocrinol Metab 85: 29–34, 2000.PubMed | ISI | Google Scholar16 Chessler SD, Fujimoto WY, Shofer JB, Boyko EJ, Weigle DS. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes 47: 239–243, 1998.Crossref | PubMed | ISI | Google Scholar17 Clegg DJ, Benoit SC, Reed JA, Woods SC, Dunn-Meynell A, Levin BE. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol 288: R981–R986, 2005.Link | ISI | Google Scholar18 Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL Caro JF. Serum immunoreactive-leptin concentrations in normal weight and obese animals. N Engl J Med 334: 292–295, 1996.Crossref | PubMed | ISI | Google Scholar19 D'Angelo G, Elmarakby AA, Pollock DM, Stepp DW. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 46: 806–811, 2005.Crossref | PubMed | ISI | Google Scholar20 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab 291: E1141–E1143, 2006.Link | ISI | Google Scholar21 de Krom M, van der Schouw YT, Hendriks J, Ophoff RA, van Gils CH, Stolk RP, Grobbee DE, Adan R. Common genetic variations in CCK, leptin, and leptin receptor genes are associated with specific human eating patterns. Diabetes 56: 276–280, 2007.Crossref | PubMed | ISI | Google Scholar22 De Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJ, Velloso LA. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 146: 4192–4199, 2005.Crossref | PubMed | ISI | Google Scholar23 El-Haschimi K, Pierroz DD, Hileman SM, Bjørbæk C, Flier JS. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105: 1827–1832, 2000.Crossref | PubMed | ISI | Google Scholar24 Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: Evidence for diet-induced resistance to leptin action. Nat Med 1: 1311–1314, 1995.Crossref | PubMed | ISI | Google Scholar25 Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94: 8878–8883, 1997.Crossref | PubMed | ISI | Google Scholar26 Hampton AG Jr, Hunt WB Jr, Mulholland HB. Insulin resistance. JAMA 161: 788–793, 1956.Crossref | PubMed | ISI | Google Scholar27 Havel PJ. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 63: 133–157, 2005.Crossref | PubMed | ISI | Google Scholar28 Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282: 1568–1575, 1999.Crossref | PubMed | ISI | Google Scholar29 Howard JK, Flier JS. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab 17: 365–371, 2006.Crossref | PubMed | ISI | Google Scholar30 Huang XF, Xin X, McLennan P, Storlien L. Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression. Diabetes Obes Metab 6: 35–44, 2004.Crossref | PubMed | ISI | Google Scholar31 Hukshorn CJ, Saris WH, Westerterp-Plantenga MS, Farid AR, Smith FJ, Campfield LA. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. J Clin Endocrinol Metab 85: 4003–4009, 2000.Crossref | PubMed | ISI | Google Scholar32 Irani BG, Dunn-Meynell AA, Levin BE. Altered hypothalamic leptin, insulin, and melanocortin binding associated with moderate-fat diet and predisposition to obesity. Endocrinology 148: 310–316, 2007.Crossref | PubMed | ISI | Google Scholar33 Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 86: 899–906, 2007.PubMed | ISI | Google Scholar34 Jürgens H, Haass W, Castañeda TR, Schürmann A, Koebnick C, Dombrowski F, Otto B, Nawrocki AR, Scherer PE, Spranger J, Ristow M, Joost HG, Havel PJ, Tschöp MH. Consuming fructose-sweetened beverages increases adiposity in mice. Obes Res 13: 1146–1156, 2005.Crossref | PubMed | Google Scholar35 Kanarek RB, Aprille JR, Hirsch E, Gualtiere L, Brown CA. Sucrose-induced obesity: effect of diet on obesity and brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 253: R158–R166, 1987.Link | ISI | Google Scholar36 Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82: 1293–1300, 1997.PubMed | ISI | Google Scholar37 Lin L, Martin R, Schaffhauser AO, York DA. Acute changes in the response to peripheral leptin with alteration in diet composition. Am J Physiol Regul Integr Comp Physiol 280: R504–R509, 2001.Link | ISI | Google Scholar38 Lin S, Storlien LH, Huang XF. Leptin receptor, NPY, POMC mRNA expression in the diet-induced obese mouse brain. Brain Res 875: 89–95, 2000.Crossref | PubMed | ISI | Google Scholar39 Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes 24: 639–646, 2000.Crossref | PubMed | ISI | Google Scholar40 Liu ZJ, Bian J, Liu J, Endoh A. Obesity reduced the gene expressions of leptin receptors in hypothalamus and liver. Horm Metab Res 39: 489–494, 2007.Crossref | PubMed | ISI | Google Scholar41 Liuzzi A, Savia G, Tagliaferri M, Lucantoni R, Berselli ME, Petroni ML, De Medici C, Viberti GC. Serum leptin concentration in moderate and severe obesity: relationship with clinical anthropometric and metabolic factors. Int J Obes Relat Metab Disord 23: 1066–1073, 1999.Crossref | PubMed | ISI | Google Scholar42 Madiehe AM, Schaffhauser AO, Braymer DH, Bray GA, York DA. Differential expression of leptin receptor in high- and low-fat-fed Osborne-Mendel and S5B/P1 rats. Obes Res 8: 467–474, 2000.Crossref | PubMed | Google Scholar43 Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1: 1155–1161, 1995.Crossref | PubMed | ISI | Google Scholar44 Mantzoros CS, Flier JS. Leptin as a therapeutic agent-trials and tribulations. J Clin Endocrinol Metab 85: 4000–4002, 2000.PubMed | ISI | Google Scholar45 Morrison CD. Leptin resistance and the response to positive energy balance. Physiol Behav 94: 660–663, 2008.Crossref | PubMed | ISI | Google Scholar46 Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625–F631, 2006.Link | ISI | Google Scholar47 Oldendorf WH. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221: 1629–1639, 1971.Link | ISI | Google Scholar48 Olsen NS, Nuetzel JA. Resistance to small doses of insulin in various clinical conditions. J Clin Invest 29: 862–866, 1950.Crossref | PubMed | ISI | Google Scholar49 Pacini G, Finegood DT, Bergman RN. A minimal-model-based glucose clamp yielding insulin sensitivity independent of glycemia. Diabetes 31: 432–441, 1982.Crossref | PubMed | ISI | Google Scholar50 Park CR, Johnson LH, Wright JH Jr, Batsel H. Effect of insulin on transport of several hexoses and pentoses into cells of muscle and brain. Am J Physiol 191: 13–18, 1957.Link | ISI | Google Scholar51 Parks EJ, Parks EJ. Changes in fat synthesis influenced by dietary macronutrient content. Proc Nutr Soc 61: 281–286, 2002.Crossref | PubMed | ISI | Google Scholar52 Robertson SA, Leinninger GM, Myers MG Jr. Molecular and neural mediators of leptin actin. Physiol Behav 94: 637–642, 2008.Crossref | PubMed | ISI | Google Scholar53 Rodin J. Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake. Am J Clin Nutr 51: 428–435, 1990.Crossref | PubMed | ISI | Google Scholar54 Rodin J, Reed D, Jamner J. Metabolic effects of fructose and glucose: implications for food intake. Am J Clin Nutr 47: 683–689, 1988.Crossref | PubMed | ISI | Google Scholar55 Roglans N, Vilà L, Farré M, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC. Impairment of hepatic Stat-3 activation and reduction of PPAR-α activity in fructose-fed rats. Hepatology 45: 778–788, 2007.Crossref | PubMed | ISI | Google Scholar56 Rosenbaum M, Leibel RL. The role of leptin in human physiology. N Engl J Med 341: 913–915, 1999.Crossref | PubMed | ISI | Google Scholar57 Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest 118: 2583–2591, 2008.PubMed | ISI | Google Scholar58 Scarpace PJ, Matheny M, Zhang Y, Shek EW, Prima V, Zolotukhin S, Tümer N. Lepti" @default.
• W2003183334 created "2016-06-24" @default.
• W2003183334 creator A5047368812 @default.
• W2003183334 date "2008-11-01" @default.
• W2003183334 modified "2023-10-15" @default.
• W2003183334 title "<i>Fructose-induced leptin resistance: discovery of an unsuspected form of the phenomenon and its significance</i>. Focus on “Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding,” by Shapiro et al." @default.
• W2003183334 cites W132026419 @default.
• W2003183334 cites W1521042725 @default.
• W2003183334 cites W16603568 @default.
• W2003183334 cites W1839209105 @default.
• W2003183334 cites W1898464912 @default.
• W2003183334 cites W1921920170 @default.
• W2003183334 cites W1964562779 @default.
• W2003183334 cites W1994069460 @default.
• W2003183334 cites W1998321044 @default.
• W2003183334 cites W2007416071 @default.
• W2003183334 cites W2013583119 @default.
• W2003183334 cites W2019217768 @default.
• W2003183334 cites W2022716990 @default.
• W2003183334 cites W2024568573 @default.
• W2003183334 cites W2027427622 @default.
• W2003183334 cites W2032777955 @default.
• W2003183334 cites W2036894421 @default.
• W2003183334 cites W2040119973 @default.
• W2003183334 cites W2041872947 @default.
• W2003183334 cites W2042535492 @default.
• W2003183334 cites W2047985768 @default.
• W2003183334 cites W2051197885 @default.
• W2003183334 cites W2057089020 @default.
• W2003183334 cites W2057919982 @default.
• W2003183334 cites W2060129133 @default.
• W2003183334 cites W2060492271 @default.
• W2003183334 cites W2066295481 @default.
• W2003183334 cites W2068300548 @default.
• W2003183334 cites W2068462949 @default.
• W2003183334 cites W2069548046 @default.
• W2003183334 cites W2070013078 @default.
• W2003183334 cites W2087133453 @default.
• W2003183334 cites W2087482176 @default.
• W2003183334 cites W2088666203 @default.
• W2003183334 cites W2092432949 @default.
• W2003183334 cites W2105476490 @default.
• W2003183334 cites W2105484754 @default.
• W2003183334 cites W2106213125 @default.
• W2003183334 cites W2106270379 @default.
• W2003183334 cites W2111231879 @default.
• W2003183334 cites W2111732109 @default.
• W2003183334 cites W2115400162 @default.
• W2003183334 cites W2115649898 @default.
• W2003183334 cites W2116843182 @default.
• W2003183334 cites W2117413045 @default.
• W2003183334 cites W2120207654 @default.
• W2003183334 cites W2124655674 @default.
• W2003183334 cites W2125510262 @default.
• W2003183334 cites W2128201148 @default.
• W2003183334 cites W2128428669 @default.
• W2003183334 cites W2129208241 @default.
• W2003183334 cites W2130059167 @default.
• W2003183334 cites W2132566507 @default.
• W2003183334 cites W2140125216 @default.
• W2003183334 cites W2140409590 @default.
• W2003183334 cites W2140499161 @default.
• W2003183334 cites W2145266375 @default.
• W2003183334 cites W2146458296 @default.
• W2003183334 cites W2146498584 @default.
• W2003183334 cites W2147788805 @default.
• W2003183334 cites W2151566924 @default.
• W2003183334 cites W2155854462 @default.
• W2003183334 cites W2163382179 @default.
• W2003183334 cites W2163599269 @default.
• W2003183334 cites W2169607998 @default.
• W2003183334 cites W2182459439 @default.
• W2003183334 cites W2332971223 @default.
• W2003183334 cites W2334337188 @default.
• W2003183334 cites W2419166189 @default.
• W2003183334 cites W4237765893 @default.
• W2003183334 cites W4251266101 @default.
• W2003183334 cites W4253640505 @default.
• W2003183334 doi "https://doi.org/10.1152/ajpregu.90674.2008" @default.
• W2003183334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18784330" @default.
• W2003183334 hasPublicationYear "2008" @default.
• W2003183334 type Work @default.
• W2003183334 sameAs 2003183334 @default.
• W2003183334 citedByCount "12" @default.
• W2003183334 countsByYear W20031833342012 @default.
• W2003183334 countsByYear W20031833342013 @default.
• W2003183334 countsByYear W20031833342014 @default.
• W2003183334 countsByYear W20031833342017 @default.
• W2003183334 countsByYear W20031833342018 @default.
• W2003183334 countsByYear W20031833342020 @default.
• W2003183334 countsByYear W20031833342021 @default.
• W2003183334 crossrefType "journal-article" @default.
• W2003183334 hasAuthorship W2003183334A5047368812 @default.
• W2003183334 hasConcept C126322002 @default.
• W2003183334 hasConcept C134018914 @default.
• W2003183334 hasConcept C147583825 @default.
• W2003183334 hasConcept C2776970464 @default.
• W2003183334 hasConcept C2777391703 @default.

• next